Albert C Lockhart MD
Gastrointestinal Cancer, Hematologic Oncology
Associate Professor, Internal Medicine, Washington University in St. Louis School of Medicine
Request Appointment
171 Ashley AveCharleston, SC 29425
Fax+1 305-243-9161
Overview of Dr. Lockhart
Dr. Albert Lockhart is an oncologist in Charleston, SC and is affiliated with MUSC Health University Medical Center. He received his medical degree from University of Texas Southwestern Medical School and has been in practice 24 years. Dr. Lockhart accepts several types of health insurance, listed below. He is one of 62 doctors at MUSC Health University Medical Center who specialize in Oncology. He has more than 100 publications and over 500 citings.
Education & Training
Duke University HospitalFellowship, Hematology and Medical Oncology, 1997 - 2000
Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 1993 - 1996
University of Texas Southwestern Medical SchoolClass of 1993
Certifications & Licensure
SC State Medical License 2021 - 2027
FL State Medical License 2017 - 2023
MO State Medical License 2008 - 2018
TN State Medical License 2001 - 2010
NC State Medical License 1999 - 2003
TX State Medical License 1995 - 2001
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2013-2017
- CMS Meaningful Use Stage Stage 2 Certification Allscripts TouchWorks EHR, Allscripts, 2013-2017
- CMS Meaningful Use Stage Stage 2 Certification Allscripts TouchWorks EHR (Complete), Allscripts, 2013-2017
Clinical Trials
- PET Scan Imaging in Assessing Response in Patients With Esophageal Cancer Receiving Combination Chemotherapy Start of enrollment: 2011 Jul 01
- Collection and Storage of Tissue and Blood Samples From Patients With Cancer Start of enrollment: 2015 May 19
Publications & Presentations
PubMed
- 2 citationsStimulating Soluble Guanylyl Cyclase with the Clinical Agonist Riociguat Restrains the Development and Progression of Castration-Resistant Prostate Cancer.Ling Zhang, Clara I Troccoli, Beatriz Mateo-Victoriano, Laura Misiara Lincheta, Erin Jackson
Cancer Research. 2025-01-02 - Phase I study of allogeneic monocyte-derived inflammatory dendritic cells in combination with pembrolizumab.Jared Weiss, Douglas Laux, David Bajor, Albert C Lockhart, John Hamm
Future Science OA. 2024-12-01 - 63 citationsDefactinib, Pembrolizumab, and Gemcitabine in Patients with Advanced Treatment Refractory Pancreatic Cancer: A Phase I Dose Escalation and Expansion Study.Andrea Wang-Gillam, Kian-Huat Lim, Robert McWilliams, Rama Suresh, Albert C Lockhart
Clinical Cancer Research. 2022-12-15
Press Mentions
US Patent for Cannabis-Derived Drug to Treat Eye DiseasesMay 22nd, 2019
Lowe’s Flavocure Secures US Patent for Ganja Eye DrugMay 17th, 2019
$10.4 Million Awarded for Pancreatic Cancer ResearchAugust 15th, 2016
Grant Support
- Medical University of South Carolina NCORP Minority/Underserved Community SiteMEDICAL UNIVERSITY OF SOUTH CAROLINA2014–2026
- Pharmacogenomically Selected Treatment For Gastric And Gastroesophageal JunctionNational Cancer Institute2008
- Genetic Polymorphisms Affecting Chemotherapy DispositionNational Cancer Institute2008
- Genetic Polymorphisms Affecting Chemotherapy DispositionNational Cancer Institute2004–2008
- Pharmacogenomically Selected Treatment For Gastric And Gastroesophageal JunctionNational Cancer Institute2007
Insurance Accepted
- Aetna Choice POS II
Aetna HMO
Anthem Blue Access Choice PPO
Anthem Blue Access PPO
BCBS Blue Card PPO
BCBS Illinois PPO
CareFirst BCBS Maryland POS
CareFirst BlueChoice Advantage
CareFirst BlueChoice Network POS
CareFirst BluePreferred PPO
CIGNA HMO
CIGNA Open AccessCIGNA PPO
Coventry Health Care PPO Platinum
Coventry Missouri - HMO/POS
First Health PPO
Great West PPO
HealthLink PPO
Humana ChoiceCare Network PPO
Multiplan PHCS PPO
Multiplan PPO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO - Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
